These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6461675)

  • 21. Retinoids and acne.
    Leyden JJ
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):164-8. PubMed ID: 2970475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nature of skin fragility in patients receiving retinoids for systemic effect.
    Williams ML; Elias PM
    Arch Dermatol; 1981 Oct; 117(10):611-9. PubMed ID: 6945067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
    Löfberg B; Reiners J; Spielmann H; Nau H
    Dev Pharmacol Ther; 1990; 15(1):45-51. PubMed ID: 2147001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of isotretinoin following a single oral dose.
    Khoo KC; Reik D; Colburn WA
    J Clin Pharmacol; 1982; 22(8-9):395-402. PubMed ID: 6957421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isotretinoin kinetics after 80 to 320 mg oral doses.
    Colburn WA; Gibson DM
    Clin Pharmacol Ther; 1985 Apr; 37(4):411-4. PubMed ID: 3856501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the atherogenic risk of isotretinoin-induced and etretinate-induced alterations of lipoprotein cholesterol metabolism.
    Melnik BC; Bros U; Plewig G
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):39s-43s. PubMed ID: 3469279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
    Larsen FG; Jakobsen P; Larsen CG; Kragballe K; Nielsen-Kudsk F
    Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic retinoids in dermatology.
    Dicken CH; Connolly SM
    Mayo Clin Proc; 1982 Jan; 57(1):51-7. PubMed ID: 6172678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General clinical toxicology of oral retinoids.
    Windhorst DB; Nigra T
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):675-82. PubMed ID: 6950955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal changes associated with chronic isotretinoin and etretinate administration.
    McGuire J; Lawson JP
    Dermatologica; 1987; 175 Suppl 1():169-81. PubMed ID: 3121403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New indications and new retinoids.
    Gollnick H
    Dermatologica; 1987; 175 Suppl 1():182-95. PubMed ID: 3319725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
    Brouwer KR; McNamara PJ
    Drug Metab Dispos; 1989; 17(6):646-51. PubMed ID: 2575501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic retinoids for acne.
    MacKie RM; Dick DC
    Lancet; 1980 Dec; 2(8207):1300-1. PubMed ID: 6108473
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
    McNamara PJ; Blouin RA
    J Pharm Sci; 1990 Apr; 79(4):301-4. PubMed ID: 2141075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
    Gollnick H; Rinck G; Bitterling T; Orfanos CE
    Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.
    Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
    Biochim Biophys Acta; 1990 Nov; 1055(2):98-101. PubMed ID: 2146977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arotinoid Ro 13-6298 and etretin: two new retinoids inferior to isotretinoin in sebum suppression and acne treatment.
    Harms M; Philippe I; Radeff B; Masouyé I; Geiger JM; Saurat JH
    Acta Derm Venereol; 1986; 66(2):149-54. PubMed ID: 2424239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of route of administration on the pharmacokinetics of etretinate in the dog.
    Bornemann LD; Cotler S; Khoo KC; Carbone JJ; Colburn WA
    Biopharm Drug Dispos; 1988; 9(1):119-26. PubMed ID: 2963666
    [No Abstract]   [Full Text] [Related]  

  • 39. Systemic retinoid therapy for psoriasis.
    Lowe NJ; Lazarus V; Matt L
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):186-91. PubMed ID: 2970476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current developments of oral retinoid therapy with three generations of drugs. Non-aromatic, monoaromatic and polyaromatic retinoids (arotinoids).
    Orfanos CE; Stadler R; Gollnick H; Tsambaos D
    Curr Probl Dermatol; 1985; 13():33-49. PubMed ID: 3156022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.